TTM
$23.59B
YoY change
+3.1%
5Y CAGR
+2.9%
Peak year (2015)
$28.63B
Cumulative gross profit
$315.44B
Gross Profit history chart for Gilead Sciences (GILD) from 1990 to 2025
Latest: $23.21B
Gross Profit growth chart for Gilead Sciences (GILD) from 1990 to 2025
Latest: +3.1%
Gross Profit history table for Gilead Sciences (GILD) from 1990 to 2025
| 2025 | $23.21B | +3.1% | +$705.00M | ||
| 2024 | $22.50B | +9.1% | +$1.89B | ||
| 2023 | $20.62B | -4.7% | −$1.01B | ||
| 2022 | $21.62B | +4.4% | +$920.00M | ||
| 2021 | $20.70B | +2.9% | +$587.00M | ||
| 2020 | $20.12B | +13.2% | +$2.34B | ||
| 2019 | $17.77B | +2.9% | +$500.00M | ||
| 2018 | $17.27B | -20.5% | −$4.46B | ||
| 2017 | $21.74B | -16.8% | −$4.39B | ||
| 2016 | $26.13B | -8.7% | −$2.50B | ||
| 2015 | $28.63B | +35.7% | +$7.53B | ||
| 2014 | $21.10B | +152.9% | +$12.76B | ||
| 2013 | $8.34B | +15.4% | +$1.11B | ||
| 2012 | $7.23B | +15.5% | +$970.02M | ||
| 2011 | $6.26B | +3.0% | +$181.43M | ||
| 2010 | $6.08B | +12.3% | +$663.72M | ||
| 2009 | $5.42B | +28.7% | +$1.21B | ||
| 2008 | $4.21B | +21.6% | +$747.23M | ||
| 2007 | $3.46B | +33.5% | +$868.46M | ||
| 2006 | $2.59B | +46.6% | +$824.75M | ||
| 2005 | $1.77B | +52.7% | +$610.04M | ||
| 2004 | $1.16B | +53.3% | +$402.86M | ||
| 2003 | $755.17M | +90.2% | +$358.11M | ||
| 2002 | $397.07M | +109.0% | +$207.06M | ||
| 2001 | $190.00M | +17.3% | +$27.96M | ||
| 2000 | $162.04M | +6.5% | +$9.94M | ||
| 1999 | $152.10M | +7.9% | +$11.20M | ||
| 1998 | $140.90M | +11.9% | +$15.00M | ||
| 1997 | $125.90M | +240.3% | +$88.90M | ||
| 1996 | $37.00M | +527.1% | +$31.10M | ||
| 1995 | $5.90M | -33.0% | −$2.90M | ||
| 1994 | $8.80M | — | — | ||
| 1992 | $5.90M | +55.3% | +$2.10M | ||
| 1991 | $3.80M | +81.0% | +$1.70M | ||
| 1990 | $2.10M | — | — |
- 2025$23.21B+3.1%
- 2024$22.50B+9.1%
- 2023$20.62B-4.7%
- 2022$21.62B+4.4%
- 2021$20.70B+2.9%
- 2020$20.12B+13.2%
- 2019$17.77B+2.9%
- 2018$17.27B-20.5%
- 2017$21.74B-16.8%
- 2016$26.13B-8.7%
- 2015$28.63B+35.7%
- 2014$21.10B+152.9%
- 2013$8.34B+15.4%
- 2012$7.23B+15.5%
- 2011$6.26B+3.0%
- 2010$6.08B+12.3%
- 2009$5.42B+28.7%
- 2008$4.21B+21.6%
- 2007$3.46B+33.5%
- 2006$2.59B+46.6%
- 2005$1.77B+52.7%
- 2004$1.16B+53.3%
- 2003$755.17M+90.2%
- 2002$397.07M+109.0%
- 2001$190.00M+17.3%
- 2000$162.04M+6.5%
- 1999$152.10M+7.9%
- 1998$140.90M+11.9%
- 1997$125.90M+240.3%
- 1996$37.00M+527.1%
- 1995$5.90M-33.0%
- 1994$8.80M—
- 1992$5.90M+55.3%
- 1991$3.80M+81.0%
- 1990$2.10M—
Gross Profit values are taken from Gilead Sciences's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Gross Profit at Gilead Sciences (GILD)
According to Gilead Sciences's latest reported financial statements, the company's current gross profit (TTM) is $23.59B. Gross profit equals revenue minus the cost of goods sold (COGS) — what remains from sales after the direct cost of producing the product or service. It does not yet subtract operating expenses, interest, or taxes (see operating income and net income for those steps). Higher gross profit (and gross margin) generally signals pricing power and production efficiency.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Gilead Sciences (GILD) most recent annual gross profit stands at $23.21B (2025) – edged up 3.1% year-over-year.
Gilead Sciences gross profit has grown for 2 consecutive years, with a +2.9% compound annual growth rate over 2020–2025 (5 years).
Gilead Sciences gross profit peaked at $28.63B in 2015; the latest annual figure is $23.21B in 2025 (18.9% below peak).
2015 marks the peak gross profit at $28.63B, with the historical low of $2.10M recorded in 1990.
Gilead Sciences Gross Profit by Year
Gilead Sciences Gross Profit 2025: $23.21B
2025's gross profit for Gilead Sciences came in at $23.21B, edged up 3.1% from 2024.
Gilead Sciences Gross Profit 2024: $22.50B
Gilead Sciences posted gross profit of $22.50B in 2024, grew 9.1% from 2023.
Gilead Sciences Gross Profit 2023: $20.62B
In 2023, Gilead Sciences reported gross profit of $20.62B, edged down 4.7% below 2022.
Gilead Sciences Gross Profit 2022: $21.62B
Gilead Sciences gross profit in 2022 was $21.62B, edged up 4.4% from 2021.
Gilead Sciences Gross Profit 2021: $20.70B
Gilead Sciences gross profit in 2021 was $20.70B.
See more financial history for Gilead Sciences (GILD).
Sector peers by Gross Profit
Healthcare peers of Gilead Sciences (GILD), ranked by their latest gross profit
| $82.92B | |
| $68.56B | |
| $54.62B | |
| $48.11B | |
| $46.73B | |
| $42.96B | |
| $39.01B | |
| $26.01B |
- $82.92B
- $68.56B
- $54.62B
- $48.11B
- $46.73B
- $42.96B
- $39.01B
- $26.01B
Frequently asked questions
Gilead Sciences (GILD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation